<DOC>
	<DOCNO>NCT02611687</DOCNO>
	<brief_summary>The purpose multicenter double blind study assess efficacy safety Pitolisant versus placebo paediatric Narcoleptic patient without cataplexy .</brief_summary>
	<brief_title>Efficacy Safety Pitolisant Pediatric Narcoleptic Patients With Without Cataplexy , Double-blind Study Followed Prolonged Open-label Period</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<criteria>Male female child 6 less 18 year age suffer narcolepsy without cataplexy ICSD3 criterion ( narcolepsy type 1 2 ) . PDSS Patients free nonauthorized medication , particular psychostimulant treatment screen visit onwards . Parents patient old enough understand express willingness participate study , sign date informed consent form prior begin protocol require procedure . In opinion investigator , patient must adequate support comply entire study requirement describe protocol ( e.g. , transportation trial site , self rating scale diary completion , drug compliance , schedule visit , test ) . Any condition consider primary cause EDS . Cataplectic patient treat anticataplectics stable treatment time inclusion . Patients treat cataplexy pathology , tricyclic antidepressant . Any significant abnormality electrocardiogram particularly Fridericia 's QTc interval . Patients significant abnormality clinical laboratory result . Psychiatric neurological disorder investigator 's opinion , would preclude patient 's participation completion trial comprise reliable representation subjective symptom . Active clinically significant illness , include unstable cardiovascular , endocrine , neoplastic , gastrointestinal , haematological , hepatic , immunologic , metabolic , neurological ( narcolepsy/cataplexy ) , pulmonary , and/or renal disease could interfere study conduct counterindicate study treatment place patient risk trial compromise study objective .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>